4//SEC Filing
Greene John 4
Accession 0001209191-23-035977
CIK 0001674416other
Filed
Jun 8, 8:00 PM ET
Accepted
Jun 9, 5:34 PM ET
Size
5.5 KB
Accession
0001209191-23-035977
Insider Transaction Report
Form 4
Greene John
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-06-08+13,000→ 13,000 totalExercise: $62.59Exp: 2033-06-08→ Common Shares (13,000 underlying)
Footnotes (1)
- [F1]This option was granted on June 8, 2023 with respect to 13,000 Common Shares with 100% of the shares vesting in 12 equal monthly installments beginning on June 30, 2023; provided that the last installment will vest on the earlier of (i) the one year anniversary of the date of grant or (ii) the date of the 2024 Annual General Meeting of Shareholders.
Documents
Issuer
CRISPR Therapeutics AG
CIK 0001674416
Entity typeother
Related Parties
1- filerCIK 0001610732
Filing Metadata
- Form type
- 4
- Filed
- Jun 8, 8:00 PM ET
- Accepted
- Jun 9, 5:34 PM ET
- Size
- 5.5 KB